Applying long-acting injectable antipsychotics in first-episode schizophrenia to achieve first remission.
Liu
Chen-Chung
CC
Chiang
Huey-Ling
HL
Wu
Szu-Ying
SY
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005475:Flupenthixol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007273:Injections, Intramuscular; D000077152:Olanzapine; D010349:Patient Compliance; D018967:Risperidone / Q000008:administration & dosage / Q000627:therapeutic use; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D055502:Secondary Prevention; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D001569:Benzodiazepines; D005475:Flupenthixol; D018967:Risperidone; D000077152:Olanzapine